King Pharmaceuticals, Inc. (KG)

dcpwcef (< 20) Submitted: 7/19/07 5:37 PM : Start Price: $17.67 KG Score: -18.91

While King is facing Altace going off patent, they performed a smart move by signing the deal with Cobalt, allowing Cobalt to be first to market with the generic. This allows two things to take place, which benefit King, and the stock value:

<...>

Report this Post Replies: 1 | Reply | Permalink

darkflame (97.48) Submitted: 5/25/07 7:24 PM : Start Price: $19.99 KG Score: -29.90

Cool news for everybody.

SQUICCIARINO JOSEPH, the Chief Finantial Officer has been accumulating shares and now owns 197,827. Ok, not so much, but some shares anyway, it's at least 2 million dollars he has himself into KG.

Then, the nicest news, it ...

Report this Post Replies: 2 | Reply | Permalink

NetscribePhrmtcl (98.19) Submitted: 12/18/06 8:24 AM : Start Price: $16.26 KG Score: 20.55

King Pharmaceuticals is not a ‘king’ anymore. Yes, the kingdom is under attack from generic competition. The company makes branded pharmaceuticals including cardiovascular, critical care, and neuroscience products.

The long-time threat of generic co...

Report this Post Replies: 2 | Reply | Permalink

davidr825 (21.46) Submitted: 9/01/06 5:19 PM : Start Price: $16.21 KG Score: -26.47

Great managemment team with the right kind of experisnce

Report this Post Replies: 0 | Reply | Permalink

healthcarevalue (98.83) Submitted: 9/14/06 2:43 AM : Start Price: $16.61 KG Score: -27.58

King Pharmaceuticals Inc. (KG) - trailing price/earnings a bit expensive at 21, but forward price/earnings is cheap at 12. Pre-tax earnings yield of 18%, pre-tax return on capital greater than 100%. Market-cap of 4 billion is small enough to potent...

Report this Post Replies: 0 | Reply | Permalink

rustyb623 (88.47) Submitted: 9/14/06 5:32 PM : Start Price: $16.71 KG Score: -28.05

Looks like it's starting to move up... balance sheet looks good... Not too sure about the long term prospects but for the short term it looks up.

Report this Post Replies: 0 | Reply | Permalink

flexnexus (44.35) Submitted: 3/01/07 7:40 PM : Start Price: $18.56 KG Score: -28.45

King's participation in Palatin's (AMEX: PTN) sexual arousal drug should pay huge dividends for them in the future. The drug works on both men and women, with low side effects. It works instantly and is inhaled. KG's marketcap is low enough so tha...

Report this Post Replies: 1 | Reply | Permalink

fct44 (97.83) Submitted: 2/19/07 3:32 PM : Start Price: $18.02 KG Score: 25.11

Showed potential for growth four years ago, but to many acquisitions caused earnings to slow. Stock is at the same price I paid for it four years ago, although recent activity has the stock price up lately, I don't expect this trend to continue with...

Report this Post Replies: 0 | Reply | Permalink

boydhar (< 20) Submitted: 3/13/08 3:22 PM : Start Price: $8.82 KG Score: 18.50

Schwab bottom-fishing stock pick. Good idea

Report this Post Replies: 0 | Reply | Permalink

ikkyu2 (99.42) Submitted: 10/12/06 3:05 AM : Start Price: $17.02 KG Score: -26.74

We like the look of their business. They're acquiring very intelligently: zaleplon for sleep, metalaxone for back pain, and they're spending the money to wring a few more years of patent life out of ramipril for the pediatric indications.

They've t...

Report this Post Replies: 1 | Reply | Permalink